Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Subir, Goyal"'
Autor:
Caroline S. Jansen, Meghana S. Pagadala, Maria A. Cardenas, Roshan S. Prabhu, Subir Goyal, Chengjing Zhou, Prasanthi Chappa, BaoHan T. Vo, Chengyu Ye, Benjamin Hopkins, Jim Zhong, Adam Klie, Taylor Daniels, Maedot Admassu, India Green, Neil T. Pfister, Stewart G. Neill, Jeffrey M. Switchenko, Nataliya Prokhnevska, Kimberly B. Hoang, Mylin A. Torres, Suzanna Logan, Jeffrey J. Olson, Edjah K. Nduom, Luke del Balzo, Kirtesh Patel, Stuart H. Burri, Anthony L. Asher, Scott Wilkinson, Ross Lake, Aparna H. Kesarwala, Kristin A. Higgins, Pretesh Patel, Vishal Dhere, Adam G. Sowalsky, Hannah Carter, Mohammad K. Khan, Haydn Kissick, Zachary S. Buchwald
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Enhancing the efficacy of immunotherapy in brain metastases (BrM) requires an improved understanding of the immune composition of BrM and how this is affected by radiation and dexamethasone. Our two-arm pilot study (NCT04895592) allocated 26
Externí odkaz:
https://doaj.org/article/f2e15d60d8c7479ea6d0d2f87a5326a2
Autor:
Nikhil T. Sebastian, Subir Goyal, Yuan Liu, Vishal Dhere, Ashesh B. Jani, Bruce Hershatter, Pretesh R. Patel, Jay W. Shelton, Sheela Hanasoge, Karen D. Godette, Sagar A. Patel
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 4, Pp 268-272 (2024)
Externí odkaz:
https://doaj.org/article/406150dafd314b69b925aefcd73e21f9
Autor:
Edouard H. Nicaise, MD, Gregory Palmateer, BA, Benjamin N. Schmeusser, MD, MS, Cameron Futral, BS, Yuan Liu, PhD, Subir Goyal, PhD, Reza Nabavizadeh, MD, David A. Kooby, MD, FACS, Shishir K. Maithel, MD, FACS, John F. Sweeney, MD, Juan M. Sarmiento, MD, FACS, Kenneth Ogan, MD, Viraj A. Master, MD, PhD, FACS
Publikováno v:
Surgery Open Science, Vol 19, Iss , Pp 172-177 (2024)
Introduction: Surgical decision-making often relies on a surgeon's subjective assessment of a patient's frailty status to undergo surgery. Certain patient demographics can influence subjective judgment when compared to validated objective assessments
Externí odkaz:
https://doaj.org/article/ea836b2e34d8466fa83cf0a59d34e077
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron, Greta Anne Russler, Lauren Yantorni, Sarah Caulfield, Jacqueline T. Brown, Jamie M. Goldman, Bassel Nazha, Bradley C. Carthon, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 52-57 (2022)
Introduction: There are three combination immune checkpoint inhibitor (ICI)–based regimens in the first-line setting for metastatic renal cell carcinoma (mRCC). Currently, there is limited real-world data for clinical outcomes and toxicity in mRCC
Externí odkaz:
https://doaj.org/article/3b523ccfbd2e4ae9ba07ac843f39a4e8
Autor:
Dan Yan, Justus M. Huelse, Dmitri Kireev, Zikang Tan, Luxiao Chen, Subir Goyal, Xiaodong Wang, Stephen V. Frye, Madhusmita Behera, Frank Schneider, Suresh S. Ramalingam, Taofeek Owonikoko, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 15 (2022)
Acquired resistance is inevitable in non–small cell lung cancers (NSCLCs) treated with osimertinib (OSI), and the mechanisms are not well defined. The MERTK ligand GAS6 promoted downstream oncogenic signaling in EGFR-mutated (EGFRMT) NSCLC cells tr
Externí odkaz:
https://doaj.org/article/dc8fcbaf4b6443d0b3ac710d3a2feecb
Autor:
Yuan Liu, Gregory Lesinski, Mark Yarchoan, Subir Goyal, Helen Chen, Amanda Ruggieri, Shishir Maithel, Bassel El-rayes, Nilofer Azad, Brian Olson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/25f37c4f8cca46cb9a7d0ca9891988cd
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Bassel Nazha, Haydn T. Kissick, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Biomarkers for mRCC patients treated with ICI are limited, and body composition is underutilized in mRCC. We investigated the as
Externí odkaz:
https://doaj.org/article/9162907753ca46b98f276622972a2ce3
Autor:
Mark W. McDonald, James E. Bates, Neal S. McCall, Subir Goyal, Yuan Liu, Soumon Rudra, Jill S. Remick, Sibo Tian, Mark W. El-Deiry, Nabil F. Saba, William A. Stokes, Erica Swinney
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:404-412
Autor:
T. Anders Olsen, Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod, Jacqueline T. Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M. Goldman, Wayne B. Harris, Omer Kucuk, Bradley C. Carthon, Viraj A. Master, Bassel Nazha, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune-checkpoint-inhibitors (ICIs) have become the cornerstone of metastatic renal-cell-carcinoma (mRCC) therapy. However, data are limited regarding clinical outcomes by race. In this study, we compared the real-world outcomes between Afr
Externí odkaz:
https://doaj.org/article/3aa9b41eb0064fb78cd9cab2b089a0c5
Autor:
Ashley Schlafstein, Subir Goyal, Ashley Aiken, Jill Remick, Nabil Saba, James Bates, Soumon Rudra, Mark McDonald, Azeem Kaka, William Stokes
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:CLO23-057